Vanguard Group Inc Sutro Biopharma, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,682,986 shares of STRO stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,682,986

Previous 4,115,250 10.5%

Holding current value

$3.5 Million

Previous $2.92 Million 10.96%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$0.72 - $1.06 $311,230 - $458,199	-432,264 Reduced 10.5%	3,682,986 $3.24 Million
Q2 2025 Aug 11, 2025	SELL	$0.52 - $1.3 $145,596 - $363,992	-279,994 Reduced 6.37%	4,115,250 $2.92 Million
Q1 2025 May 09, 2025	BUY	$0.65 - $2.12 $121,383 - $395,897	186,744 Added 4.44%	4,395,244 $2.86 Million
Q4 2024 Feb 11, 2025	BUY	$1.82 - $4.4 $24,438 - $59,083	13,428 Added 0.32%	4,208,500 $7.74 Million
Q3 2024 Nov 13, 2024	BUY	$2.88 - $5.01 $1.84 Million - $3.21 Million	639,732 Added 17.99%	4,195,072 $14.5 Million
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.33 $1.56 Million - $2.84 Million	532,550 Added 17.62%	3,555,340 $10.4 Million
Q1 2024 May 10, 2024	BUY	$3.27 - $5.65 $434,223 - $750,263	132,790 Added 4.59%	3,022,790 $17.1 Million
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $43,962 - $96,420	21,238 Added 0.74%	2,890,000 $12.4 Million
Q3 2023 Nov 14, 2023	BUY	$3.29 - $4.9 $127,829 - $190,384	38,854 Added 1.37%	2,868,762 $9.95 Million
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $225,020 - $311,322	52,946 Added 1.91%	2,829,908 $13.2 Million
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $592,659 - $1.12 Million	132,290 Added 5.0%	2,776,962 $12.8 Million
Q4 2022 Feb 10, 2023	BUY	$5.41 - $8.08 $3.22 Million - $4.8 Million	594,396 Added 28.99%	2,644,672 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $66,956 - $92,081	12,951 Added 0.64%	2,050,276 $11.4 Million
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $660,421 - $1.73 Million	-193,672 Reduced 8.68%	2,037,325 $10.6 Million
Q1 2022 May 13, 2022	BUY	$7.78 - $15.31 $880,618 - $1.73 Million	113,190 Added 5.34%	2,230,997 $18.3 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $39,558 - $65,319	2,776 Added 0.13%	2,117,807 $31.5 Million
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $874,991 - $1.16 Million	51,836 Added 2.51%	2,115,031 $40 Million
Q2 2021 Aug 13, 2021	BUY	$18.03 - $23.82 $37.2 Million - $49.1 Million	2,063,195 New	2,063,195 $38.4 Million

Others Institutions Holding STRO

# of Institutions

Shares Held

57.3M

Call Options Held

75K

Put Options Held

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $49.6M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sutro Biopharma, Inc. Transaction History